Discovery of gene involved in fatty liver disease

April 24, 2013

An international research consortium led by CIC bioGUNE has discovered the involvement of a gene in the development of non-alcoholic fatty liver disease (NAFLD). Although the gene concerned (SLC2A1) had never previously been linked to liver disease, it appears to be involved in the development of this disorder. NAFLD is currently one of the leading causes of chronic liver disease in the world.

It was already known that, as well as environmental aspects (lifestyle, diet, etc.), the likelihood of developing NAFLD was also affected by , although the concerned are poorly defined. The aim of this study was to identify genetic variants associated with this disease in order to gain a better understanding of the genetics behind its development. The final goal of the study was therefore to try identifying new targets for the diagnosis and treatment of this disease.

This work, which was published recently in the leading scientific journal Hepatology, was undertaken by 20 institutions from Spain, France, Germany, Denmark and the USA, with Basque institutions playing a key role. Thus, as well as CIC bioGUNE, the company OWL Genomics, the Physiology Department at the UPV/EHU School of Medicine and the Galdakao Hospital all took part in this research.

The research

The initial phase of the study involved searching for variations in the DNA sequence of 92 genes, which had shown to be likely candidates by previous studies. DNA from 69 patients diagnosed with NAFLD and 217 health individuals was used. Various genes that exhibited significant differences in their sequence were identified and studied again in a different cohort of 451 NAFLD patients and 304 healthy individuals.

The correlation of NAFLD and high frequency of changes in the sequence for SLC2A1 was found at this stage. Once this relationship had been found, it was studied whether the presence of this gene at an RNA level was the same in the livers of healthy individuals and NAFLD patients. This study showed that from the SLC2A1 gene was present at much lower levels in NAFLD patients.

Finally, an in vitro test with hepatocytes (one of the main cell types in the liver) showed that inhibition of SLC2A1 gene expression resulted in much greater accumulation of lipids than in cells with normal levels of this gene, as well as greater oxidative damage. These are the most representative characteristics of liver status in NAFLD patients.

According to the CIC bioGUNE researcher Ana M. Aransay, who headed the project, "involvement of the SLC2A1 gene in NAFLD still needs to be confirmed in other patient populations from other countries", adding that "as NAFLD is a complex disease, our findings must be interpreted in light of the results of other recent studies".

"Thus", continued Aransay, "an understanding of the development of NAFLD must take into account all the causes of this disease, especially genetic and environmental factors, as well as the interaction between them. An interpretation of the interactions that arise will help us to describe the reality of many complex diseases".

NAFLD

NAFLD is a progressive disease that ranges from fatty liver build-up (steatosis) to non-alcoholic steatohepatitis (NASH), which is inflammation around the fats. Non-alcoholic is the most common in Europe and the USA, and its prevalence is currently increasing in many other regions of the world, especially Asia and India.

The prevalence of steatosis and NASH in adults in the Western countries is around 30% and 3%, respectively. NASH is the most serious manifestation of NAFLD as around 20% of NASH patients go on to develop cirrhosis within 10 years, with over a quarter of these patients subsequently developing hepatocellular carcinoma (HCC), or liver cancer, after around 10 years.

Explore further: Gene variant ID could lead to better fatty liver disease diagnosis

More information: Vazquez-Chantada, M. et al. Solute Carrier Family 2 Member1 Is Involved in the Development of Nonalcoholic Fatty Liver Disease, Hepatology Volume 57, Issue 2, pages 505–514, February 2013.

Related Stories

Gene variant ID could lead to better fatty liver disease diagnosis

April 23, 2013
More patients could be diagnosed earlier with non-alcoholic fatty liver disease (NAFLD) after a cohort study presented at the International Liver CongressTM 2013 identified variants within four genes significantly associated ...

Modest alcohol intake associated with less inflammation in patients with common liver disease

May 15, 2012
NAFLD (non-alcoholic fatty liver disease) is the most common type of liver disease in the developed world, affecting up to one-third of the US population. NAFLD is often associated with obesity and other parameters of the ...

Liver cancer incidence lower in patients with nonalcoholic fatty liver disease than hepatitis C

September 27, 2011
Patients with non-alcoholic fatty liver disease (NAFLD) with advanced fibrosis or cirrhosis have a lower incidence of liver-related complications and hepatocellular carcinoma (HCC) than patients infected with hepatitis C ...

NAFLD independently linked to cardiovascular disease

June 7, 2012
(HealthDay) -- Nonalcoholic fatty liver disease (NAFLD) is independently associated with an increased risk of cardiovascular disease (CVD), but it is not associated with a statistically significantly increased risk of cardiovascular ...

Coffee consumption reduces fibrosis risk in those with fatty liver disease

February 2, 2012
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces ...

Cardiovascular issues up mortality rates in patients with advanced fibrosis

April 10, 2013
New research reveals that advanced fibrosis is a significant predictor of mortality in patients with nonalcoholic fatty liver disease (NAFLD), largely brought about by cardiovascular causes. NAFLD alone was not associated ...

Recommended for you

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly discovered gene variants link innate immunity and Alzheimer's disease

July 17, 2017
Three new gene variants, found in a genome wide association study of Alzheimer's disease (AD), point to the brain's immune cells in the onset of the disorder. These genes encode three proteins that are found in microglia, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.